Philip Reigan

University Of Colorado Denver

$2,271,458

Attributed

$2,429,695

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $390K · FY2013–25

$500K$375K$250K$125K$0

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$2,429,695 · 3

By mechanism

R01$1,690,278 · 1

R21$422,943 · 1

R43$316,474 · 1

Top collaborators

Boris Tabakoff2 shared

Most similar at University Of Colorado Denver

Same institution · by research overlap

Boris Tabakoff$49,372,989
Heide L Ford$14,422,349
Jelena Klawitter$763,494
Jost Klawitter$1,117,920
Emily Lindley$240,594

Others in their field

Top investigators on “In Vitro”

David Heimbrook · Leidos Biomedical Research, Inc.$553,787,942
Leonard Freedman · Leidos Biomedical Research, Inc.$310,441,779
Mark S Klempner · Tufts Medical Center$128,021,180
Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
Lynn Briscoe · Leidos Biomedical Research, Inc.$94,686,873
Dennis R. Burton · Scripps Research Institute$79,204,175

Research focus

In VitroMolecularIn VivoCellsPropertyDesignChemotherapyDrug TargetingSeriesPhosphotransferasesPathway InteractionsDrug ResistanceXenograft ModelClinicResistanceLeadMediatingInterestCell SurvivalMetabolismBaseAcute Myelocytic LeukemiaConsumptionConventional Therapy